FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis (PR Newswire via Yahoo! Finance)
The U.S. Food and Drug Administration approved a new once-a-month dose of Actonel® tablets for the treatment and prevention of postmenopausal osteoporosis.